Does Rallies show 13F holders for GKOS?

Yes. Rallies tracks hedge fund and 13F ownership data for GKOS, including fund names, share counts, latest tracked quarter, and position changes when available.

Is GKOS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GKOS. It does not provide personalized investment advice.

GKOS (Glaukos Corporation) Stock Analysis - Hedge Fund Holdings

Glaukos Corporation (GKOS) is a publicly traded Healthcare sector company. As of May 21, 2026, GKOS trades at $137.25 with a market cap of $8.35B and a P/E ratio of -44.00. GKOS moved -2.54% today. Year to date, GKOS is +27.83%; over the trailing twelve months it is +47.52%. Its 52-week range spans $73.16 to $163.71. Analyst consensus is strong buy with an average price target of $142.91. Rallies surfaces GKOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns GKOS stock?

Hedge funds tracked by Rallies that own GKOS include Eisler Capital, Centerbook Partners, Farallon Capital, and Bridgewater Associates. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Glaukos Corporation.

GKOS Key Metrics

Key financial metrics for GKOS
Metric	Value
Price	$137.25
Market Cap	$8.35B
P/E Ratio	-44.00
EPS	$-3.28
Dividend Yield	0.00%
52-Week High	$163.71
52-Week Low	$73.16
Volume	22.73K
Avg Volume	0
Revenue (TTM)	$507.44M
Net Income	$-187.69M
Gross Margin	55.72%

Top Hedge Funds Holding GKOS

Eisler Capital holds 39.03K shares of GKOS, changed +0.00% as of Jun 30, 2024.
Centerbook Partners holds 13.26K shares of GKOS, changed +443.77% as of Dec 31, 2025.
Farallon Capital holds 2.60K shares of GKOS, changed +0.00% as of Mar 31, 2026.
Bridgewater Associates holds 2.36K shares of GKOS, changed -59.52% as of Mar 31, 2025.

Latest GKOS News

Glaukos dips 3% as new 8-K investor deck sparks post-earnings profit-taking — May 4, 2026
Glaukos jumps on record Q1 sales, iDose TR strength, and raised 2026 outlook — Apr 30, 2026
Glaukos Raises 2026 Sales Guidance to $620–$635M After 41% Q1 Revenue Surge — Apr 30, 2026
Glaukos slides 3% as traders de-risk ahead of Q1 earnings after the close — Apr 29, 2026
Glaukos jumps as Citi upgrades to Buy and raises target to $162 — Apr 17, 2026

Recent GKOS Insider Trades

Kliman Gilbert H sold 5.00K (~$703.80K) on May 14, 2026.
Kliman Gilbert H sold 5.00K (~$675.00K) on May 11, 2026.
Gilliam Joseph E sold 19.57K (~$2.81M) on May 1, 2026.

GKOS Analyst Consensus

12 analysts cover GKOS: 0 strong buy, 11 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $142.91.

Common questions about GKOS

Who owns GKOS stock?: Hedge funds tracked by Rallies that own GKOS include Eisler Capital, Centerbook Partners, Farallon Capital, and Bridgewater Associates. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Glaukos Corporation.
Does Rallies show 13F holders for GKOS?: Yes. Rallies tracks hedge fund and 13F ownership data for GKOS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is GKOS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GKOS. It does not provide personalized investment advice.